COVID19-associated new-onset movement disorders: a follow-up study.
Susanne A SchneiderSoaham DesaiOnanong PhokaewvarangkulElena Cecilia RoscaJirada SringeanPria AnandGary Álvarez BravoFrancisco CardosoAnna M Cervantes-ArslanianHarshad ChovatiyaDavid CrosiersFemke DijkstraConor FearonFrancisco GrandasEric GuedjAntonio Méndez-GuerreroMuhammad HassanJoseph JankovicAnthony E LangKarim MakhoulLorenzo MuccioliSarah A O'SheaVahid Reza OstovanJavier Ricardo Perez-SanchezRitesh RamdhaniVictoria Ros-CastellóChristina SchultePriyank ShahLars WojteckiPramod Kumar PalPublished in: Journal of neurology (2023)
The prognosis of new-onset COVID-19-associated movement disorder appears to be generally good. The majority recovered without residual symptoms within several weeks or months. Permanent cases may be due to unmasking of a previous subclinical movement disorder or due to vascular/demyelinating damage. Given the relatively low response rate of one third only and the heterogeneity of mechanisms firm conclusions on the (long-term) outome cannot, however, be drawn.